Enter assignee name

% Expired Patents = 71.4

Forward Citations = 794

Loading Chart...

4 inventors (with patents filed for the assignee):

John Daniel Dobak, Iii (4 out of 115 patents)

John D Dobak (2 out of 4 patents)

Hans Neisz (1 out of 3 patents)

4. Hugh Louis Narciso, Jr (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 7702386 - Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes (2010-04-20),

2. 7689277 - Neural stimulation for treatment of metabolic syndrome and type 2 diabetes (2010-03-30),

3. 7689276 - Dynamic nerve stimulation for treatment of disorders (2010-03-30),

4. 7623924 - Devices and methods for gynecologic hormone modulation in mammals (2009-11-24),

5. 7551964 - Splanchnic nerve stimulation for treatment of obesity (2009-06-23),

6. 7239912 - Electric modulation of sympathetic nervous system (2007-07-03),

7. 7236822 - Wireless electric modulation of sympathetic nervous system (2007-06-26),

Leptos Biomedical, Inc. is a leading biotechnology company focused on developing innovative solutions for the diagnosis and treatment of neurological disorders. With a strong emphasis on research and development, Leptos is dedicated to improving the lives of patients through groundbreaking medical advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#3 in Fridley, MN

#1,120 in Minnesota

#39,856 in US

Fridley, MN, United States of America

Leptos Biomedical, Inc.

Forward Citations = 794

4 inventors:

John Daniel Dobak, Iii (4 out of 115 patents)

John D Dobak (2 out of 4 patents)

Hans Neisz (1 out of 3 patents)

4. Hugh Louis Narciso, Jr (1 out of 1 patent)

Please report any incorrect information to [email protected]